NCT02190175View on ClinicalTrials.gov

Management of Atrial Fibrillation With Flecainide : the AFFLEC Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Atrial Fibrillation
Trial Locations (3)

11526

Erythros Stavros Hospital, Athens

41110

University Hospital of Larisa, Larissa

54636

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

Hellenic Cardiovascular Research Society

OTHER

NCT02190175 - Management of Atrial Fibrillation With Flecainide : the AFFLEC Study | Biotech Hunter | Biotech Hunter